ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 111 filers reported holding ROIVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,314,485,140 | +6.4% | 112,541,536 | -8.2% | 74.33% | +9.9% |
| Q2 2023 | $1,235,218,683 | +36.6% | 122,541,536 | 0.0% | 67.65% | +52.1% |
| Q1 2023 | $904,356,536 | -7.6% | 122,541,536 | 0.0% | 44.47% | -13.9% |
| Q4 2022 | $979,106,873 | +135.0% | 122,541,536 | -5.3% | 51.63% | +77.6% |
| Q3 2022 | $416,648,000 | -20.9% | 129,393,817 | 0.0% | 29.07% | -12.4% |
| Q2 2022 | $526,633,000 | -17.6% | 129,393,817 | 0.0% | 33.18% | +19.6% |
| Q1 2022 | $639,205,000 | -51.0% | 129,393,817 | 0.0% | 27.73% | -38.0% |
| Q4 2021 | $1,304,290,000 | – | 129,393,817 | – | 44.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $11,284,449 | 97.24% |
| QVT Financial LP | 122,541,536 | $1,235,218,683 | 67.65% |
| Patient Square Capital LP | 12,639,920 | $127,410,394 | 62.03% |
| Two Seas Capital LP | 7,909,591 | $79,728,677 | 17.43% |
| SB INVESTMENT ADVISERS (UK) LTD | 83,031,667 | $836,959,203 | 6.38% |
| Octagon Capital Advisors LP | 3,904,000 | $39,352,320 | 5.48% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $48,713,031 | 4.30% |
| VIKING GLOBAL INVESTORS LP | 75,238,700 | $758,406,096 | 3.10% |
| HSG Holding Ltd | 2,595,838 | $26,166,047 | 2.99% |
| Artia Global Partners LP | 824,363 | $8,309,579 | 2.86% |